Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000003

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — president · 10% Owner
Period of report
Dec 12, 2016
Accepted (ET)
Feb 24, 2017 · 1:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
COMMON STOCKDec 12, 2016P1,000$0.0668A19,593,415D
COMMON STOCKDec 13, 2016P1,000$0.0667A19,594,415D
COMMON STOCKDec 13, 2016P950$0.0667A19,595,365D
common STOCKDec 13, 2016P50$0.0661A19,595,415D
COMMON STOCKDec 16, 2016P1,000$0.0667A19,596,415D
COMMON STOCKDec 16, 2016P1,000$0.0666A19,597,415D
COMMON STOCKDec 16, 2016P1,000$0.0655A19,598,415D
COMMON STOCKDec 16, 2016P50$0.0655A19,598,465D
COMMON STOCKDec 16, 2016P950$0.0665A19,599,415D
Common StockDec 16, 2016P1,000$0.066A19,600,415D
Common StockDec 19, 2016P1,000$0.066A19,601,415D
Common StockDec 19, 2016P50$0.0645A19,601,465D
Common StockDec 19, 2016P950$0.066A19,602,415D
Common StockDec 19, 2016P1,000$0.0695A19,603,415D
Common StockDec 19, 2016P1,000$0.068A19,604,415D
Common StockDec 19, 2016P50$0.0673A19,604,465D
Common StockDec 19, 2016P950$0.0685A19,605,415D
Common StockDec 19, 2016P200$0.0658A19,605,615D
Common StockDec 22, 2016P1,000$0.0559A19,606,615D
Common StockDec 22, 2016P1,000$0.0554A19,607,615D
Common StockDec 22, 2016P1,000$0.0559A19,608,615D
Common StockDec 23, 2016P1,000$0.064A19,609,615D
Common StockDec 23, 2016P1,000$0.063A19,610,615D
Common StockDec 23, 2016P1,000$0.0615A19,611,615D
Common StockDec 27, 2016P1,000$0.0569A19,612,615D
Common StockDec 27, 2016P1,000$0.0597A19,613,615D
Common StockDec 28, 2016P1,000$0.0552A19,614,615D
Common StockDec 28, 2016P1,000$0.055A19,615,615D
Common StockDec 28, 2016P200$599.00A19,615,815D
Common StockDec 28, 2016P300$0.0599A19,616,115D

Table II — derivative securities

No Table II lines on this filing.